{"transactions":[{"id":772911,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":46092,"kind":"person","name":"Frohlich Mark W","position":1,"cik":"0001420482","reported_name":"Frohlich Mark W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-20T00:48:40.000Z","date":"2026-05-15","kind":"grant","planned":false,"acquired":true,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors."}],"balance_after":7000,"source":{"system":"sec-edgar","filing":"0000905148-26-002530","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000090514826002530/form4.xml","form_type":"4"}},{"id":1132343,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":46092,"kind":"person","name":"Frohlich Mark W","position":1,"cik":"0001420482","reported_name":"Frohlich Mark W","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-28T21:26:40.000Z","date":"2025-05-23","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vest monthly over one (1) year from the date of grant, subject to the Reporting Person's continuous service on the Company's Board of Directors."}],"balance_after":1500,"derivative":{"exercise_price":18.95,"expiration_date":"2035-05-23","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0000905148-25-001931","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000090514825001931/form4.xml","form_type":"4"}},{"id":1132342,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":46092,"kind":"person","name":"Frohlich Mark W","position":1,"cik":"0001420482","reported_name":"Frohlich Mark W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-28T21:26:40.000Z","date":"2025-05-23","kind":"grant","planned":false,"acquired":true,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors."}],"balance_after":1250,"source":{"system":"sec-edgar","filing":"0000905148-25-001931","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000090514825001931/form4.xml","form_type":"4"}},{"id":1215707,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":46092,"kind":"person","name":"Frohlich Mark W","position":1,"cik":"0001420482","reported_name":"Frohlich Mark W","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-03-10T21:42:13.000Z","date":"2025-03-06","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in equal monthly installments over a period beginning on March 6, 2025 and ending on the date of the annual meeting at which the Reporting Person is first scheduled to be considered for election by the stockholders, subject to the Reporting Person's continuous service on the Company's Board of Directors."}],"balance_after":12000,"derivative":{"exercise_price":19.7,"expiration_date":"2035-03-06","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000905148-25-000899","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000090514825000899/form4.xml","form_type":"4"}}]}